DFC
ELV icon

DB Fitzpatrick & Co’s Elevance Health ELV Stock Holding History

DB Fitzpatrick & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
5,006
-413
-8% -$153K 1.56% 13
2026
Q1 		$1.59M Buy
5,419
+1,061
+24% +$349K 1.36% 16
2025
Q4 		$1.53M Sell
4,358
-1,022
-19% -$345K 1.36% 16
2025
Q3 		$1.74M Buy
5,380
+1,028
+24% +$320K 1.57% 13
2025
Q2 		$1.69M Buy
4,352
+47
+1% +$18.9K 1.5% 12
2025
Q1 		$1.87M Sell
4,305
-311
-7% -$125K 1.78% 6
2024
Q4 		$1.7M Buy
4,616
+581
+14% +$243K 1.57% 14
2024
Q3 		$2.1M Buy
4,035
+305
+8% +$163K 1.84% 9
2024
Q2 		$2.02M Sell
3,730
-29
-0.8% -$15.3K 1.87% 6
2024
Q1 		$1.95M Buy
3,759
+136
+4% +$67.6K 1.79% 10
2023
Q4 		$1.71M Sell
3,623
-175
-5% -$80.9K 1.64% 10
2023
Q3 		$1.65M Buy
3,798
+85
+2% +$38.6K 1.77% 8
2023
Q2 		$1.65M Buy
3,713
+263
+8% +$121K 1.74% 10
2023
Q1 		$1.59M Buy
3,450
+922
+36% +$439K 1.72% 12
2022
Q4 		$1.3M Buy
2,528
+385
+18% +$195K 1.49% 19
2022
Q3 		$973K Sell
2,143
-672
-24% -$322K 1.18% 31
2022
Q2 		$1.36M Buy
2,815
+29
+1% +$14.3K 1.5% 17
2022
Q1 		$1.37M Buy
2,786
+46
+2% +$21K 1.36% 26
2021
Q4 		$1.27M Buy
+2,740
New +$1.15M 1.19% 29

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

DB Fitzpatrick & Co's ELV Position: Q2 2026 in Review

DB Fitzpatrick & Co reduced its Elevance Health (ELV) stake by 7.6% in Q2 2026, selling an estimated $153K and leaving 5,006 shares worth $1.94M. The position accounts for 1.56% of the portfolio, ranked #13.

DB Fitzpatrick & Co first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.1M in Q3 2024. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • DB Fitzpatrick & Co held 5,006 shares of Elevance Health worth $1.94M as of Q2 2026.
  • DB Fitzpatrick & Co sold 413 Elevance Health shares in Q2 2026, an estimated $153K.
  • Elevance Health made up 1.56% of DB Fitzpatrick & Co's portfolio in Q2 2026, its #13 holding.
  • DB Fitzpatrick & Co first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • DB Fitzpatrick & Co's Elevance Health position peaked at $2.1M in Q3 2024.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on DB Fitzpatrick & Co's 13F filing for Q2 2026, filed 15 Jul 2026.